Piper Sandler Analysts Reduce Earnings Estimates for Molina Healthcare, Inc. (NYSE:MOH)

Share on StockTwits

Molina Healthcare, Inc. (NYSE:MOH) – Stock analysts at Piper Sandler decreased their Q1 2020 earnings per share (EPS) estimates for Molina Healthcare in a note issued to investors on Tuesday, February 11th. Piper Sandler analyst S. James now forecasts that the company will post earnings per share of $2.83 for the quarter, down from their previous forecast of $3.30. Piper Sandler also issued estimates for Molina Healthcare’s Q2 2020 earnings at $3.02 EPS, Q4 2020 earnings at $2.84 EPS and FY2020 earnings at $11.70 EPS.

Other equities analysts also recently issued research reports about the company. Cfra lifted their price objective on Molina Healthcare from $128.00 to $141.00 and gave the company a “hold” rating in a research report on Tuesday. Deutsche Bank boosted their target price on Molina Healthcare from $145.00 to $150.00 and gave the stock a “buy” rating in a research report on Tuesday, January 7th. Jefferies Financial Group downgraded Molina Healthcare from a “buy” rating to a “hold” rating and dropped their target price for the stock from $133.00 to $120.00 in a research report on Wednesday, October 30th. JPMorgan Chase & Co. boosted their target price on Molina Healthcare from $150.00 to $152.00 and gave the stock an “overweight” rating in a research report on Friday, December 20th. Finally, BMO Capital Markets boosted their target price on Molina Healthcare from $152.00 to $170.00 and gave the stock an “outperform” rating in a research report on Wednesday. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $152.10.

Shares of MOH opened at $144.99 on Friday. The stock has a fifty day moving average price of $134.77 and a two-hundred day moving average price of $127.97. The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.78 and a current ratio of 1.78. Molina Healthcare has a 52-week low of $106.50 and a 52-week high of $159.00. The company has a market cap of $8.11 billion, a price-to-earnings ratio of 12.64, a PEG ratio of 1.15 and a beta of 1.15.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Monday, February 10th. The company reported $2.73 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.65 by $0.08. Molina Healthcare had a return on equity of 41.71% and a net margin of 4.38%. The firm had revenue of $4.27 billion during the quarter, compared to the consensus estimate of $4.28 billion. During the same quarter in the previous year, the company posted $3.07 EPS. The business’s revenue for the quarter was down 8.4% compared to the same quarter last year.

In other news, Director Dale B. Wolf sold 3,500 shares of the business’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $135.51, for a total transaction of $474,285.00. Following the completion of the sale, the director now owns 8,461 shares in the company, valued at $1,146,550.11. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.77% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the company. Victory Capital Management Inc. increased its holdings in Molina Healthcare by 3,621.0% in the fourth quarter. Victory Capital Management Inc. now owns 1,032,913 shares of the company’s stock valued at $127,017,000 after purchasing an additional 1,005,154 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in Molina Healthcare by 105.3% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,042,744 shares of the company’s stock valued at $141,490,000 after purchasing an additional 534,757 shares during the last quarter. Boston Partners increased its holdings in Molina Healthcare by 60.1% in the third quarter. Boston Partners now owns 927,312 shares of the company’s stock valued at $101,789,000 after purchasing an additional 348,151 shares during the last quarter. Bank of Montreal Can increased its holdings in Molina Healthcare by 176.7% in the fourth quarter. Bank of Montreal Can now owns 360,440 shares of the company’s stock valued at $48,908,000 after purchasing an additional 230,182 shares during the last quarter. Finally, Bank of America Corp DE increased its holdings in Molina Healthcare by 79.9% in the fourth quarter. Bank of America Corp DE now owns 423,114 shares of the company’s stock valued at $57,413,000 after purchasing an additional 187,906 shares during the last quarter. Institutional investors own 95.64% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

See Also: How to Invest in an Index Fund

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Hasbro, Inc.  Expected to Earn Q1 2020 Earnings of $0.01 Per Share
Hasbro, Inc. Expected to Earn Q1 2020 Earnings of $0.01 Per Share
Halozyme Therapeutics, Inc.  to Post Q1 2020 Earnings of  Per Share, Piper Sandler Forecasts
Halozyme Therapeutics, Inc. to Post Q1 2020 Earnings of Per Share, Piper Sandler Forecasts
Q1 2020 EPS Estimates for Helios Technologies  Boosted by William Blair
Q1 2020 EPS Estimates for Helios Technologies Boosted by William Blair
Aergo Price Down 15.4% This Week
Aergo Price Down 15.4% This Week
Skychain  Market Capitalization Achieves $662,118.00
Skychain Market Capitalization Achieves $662,118.00
EveriToken  Trading Down 27.4% Over Last Week
EveriToken Trading Down 27.4% Over Last Week


 
© 2006-2020 Zolmax.